# Karman Holdings Inc. (KRMN) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare. Price $39.98, market value $5.3 billion.

## Valuation
- **P/E (trailing): 148.1×** (5-yr avg 562.8×, 3-yr avg 562.8×). Karman Holdings Inc. trades at 148.1× trailing earnings, well below its own five-year average of 562.8×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 42.3×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.68**. A PEG of 0.68 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 9.0×**. Each dollar of revenue is priced at 9.0×.
- **Price / book: 12.6×**. The shares trade at 12.6× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 34.1×**. Enterprise value is 34.1× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: -0.5%** (5-yr avg -0.4%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 0.7%**. The inverse of the P/E: 0.7% of the price is earned each year.

## Profitability
- **Gross margin: 41.7%**. Karman Holdings Inc. keeps 41.7% of revenue after the direct cost of what it sells.
- **Operating margin: 16.8%**. 16.8% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 3.7%**. 3.7% of each dollar of sales reaches the bottom line.
- **Return on equity: 4.5%**. 4.5% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 22.2%**. Return on all capital, debt included, is 22.2%: comfortably above what that capital costs.
- **Return on assets: 3.4%**. Each dollar of assets produces 3.4% of profit.

## Growth
- **Revenue growth (1 yr): 36.6%** (3-yr 27.7%/yr). Revenue grew 36.6% over the last year.
- **EPS growth (1 yr): 62.5%**. Earnings per share rose 62.5%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.01**. Debt is 0.01 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Karman Holdings Inc. holds more cash than debt.
- **Altman Z-score: 5.54**. A Z-score of 5.54 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Karman Holdings Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (10 analysts). 10 analysts cover Karman Holdings Inc.; the consensus is buy, with an average price target of $87.10 (+118% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -25.1%** (YTD -45.4%, 3-mo -19.1%). The shares are down 25.1% over twelve months including dividends.
- **From 52-week high: -66.2%** (2.0% above the low). Trading 66% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 26**. An RSI of 26 is oversold; bounces are common, but oversold can stay oversold in a real decline.
- **Beta (1 yr): 2.29** (volatility 73%). Beta of 2.29 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=KRMN · Page: https://foliofundamentals.com/stocks/krmn

Not investment advice.